A new study published in the journal New Solutions presents strong evidence that women employed in the plastics industry are exposed to workplace chemicals that can increase their risk of breast cancer and reproductive abnormalities.
Dec 7, 2012
0
0
(HealthDay)—For women with estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, the investigational agent PD 0332991 plus letrozole improves progression-free survival versus ...
Dec 5, 2012
0
0
Women with polycystic ovary syndrome (PCOS) who are taking combined oral contraceptives have a 2-fold risk of blood clots compared with women without the disorder who take contraceptives, states a study published in CMAJ ...
Dec 3, 2012
0
1
In utero exposure to bisphenol A (BPA) can be associated with decreased thyroid function in newborn sheep, according to a recent study accepted for publication in Endocrinology. Hypothyroidism is characterized by poor mental ...
Nov 14, 2012
0
0
(Medical Xpress)—The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new ...
Oct 24, 2012
0
0
A common herbicide used in the United States may be linked to an increased risk of a congenital abnormality of the nasal cavity known as choanal atresia, say researchers at Baylor College of Medicine and other Texas institutions.
Sep 28, 2012
0
0
The FDA says baby bottles and sippy cups can no longer contain Bisphenol-A (BPA), an endocrine disruptor that mimics estrogen. But what about the hundreds of other plastic items, from water bottles to dental sealants, containing ...
Jul 23, 2012
0
0
Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR ...
Apr 1, 2012
0
0
Endocrine-disrupting chemicals (EDCs) -- such as BPA -- can show tangible effects on health endpoints at high dosage levels, yet those effects do not predict how EDCs will affect the endocrine system at low doses, according ...
Mar 29, 2012
0
0
A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted. Results of the clinical trial conducted ...
Mar 7, 2012
0
0
